Paul Bryant

Chief Technology Officer of MicroPort Orthopedics Inc.

Paul Bryant has been the chief technology officer of MicroPort Orthopedics Inc. since March 2016, responsible for portfolio enhancements and advancements in key technologies through internal and external developments and partnerships. During his time at MicroPort Orthopedics, he has led various groups including Research and Development, Engineering Operations, and Global Marketing. Bryant has a strong record of achievements in product development and commercialization, global portfolio management, strategic planning, and account management. Prior to joining MicroPort Orthopedics, he led the marketing and product management efforts for Cardinal Health's Orthopedic Solutions business. He also spent time at Baxter in both upstream and downstream marketing roles within their BioSurgery franchise. Bryant joined Zimmer in 2006 and over the next six years, he held several commercial roles, which included managing the global marketing efforts for various knee and sports medicine product lines and leading the U.S. sales strategies as part of the Corporate Sales team. Bryant started his career at The Dow Chemical Company as a research engineer within the Research Assignments Program. During his 10 years at Dow, he held various technical and commercial roles across several businesses within the organization. Bryant holds a B.S. in Chemical Engineering from Wayne State University in Detroit and an M.B.A. from the University of Michigan in Ann Arbor and has followed additional Executive Education at the University of Chicago.

1:45-2:35 p.m.

Wednesday April 24, 2024

Design Considerations: Developing Products for the ASC Environment

A major shift is happening within the orthopedic device space. More procedures are moving out of the hospitals and into ambulatory surgical centers (ASC). With this shift comes a different set of demands from orthopedic device manufacturers, from instruments to implants to other surgical equipment. Further, product packaging, sterilization concerns, and available space are all factors impacting the development of these technologies. Hear from representatives who are intimately involved with this transition and what aspects they have identified as needing to be addressed.

Moderated by Paul Bryant